MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

Stocks Yahoo Finance By Yahoo Finance 05 Jun 2026 21:56 1 min read

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.